RBC Capital analyst Frank Morgan reiterated a Buy rating on UnitedHealth (NYSE: UNH) yesterday and set a price target of $284. The company’s shares closed yesterday at $250.29, close to its 52-week high of $259.01.
According to TipRanks.com, Morgan is a 5-star analyst with an average return of 15.4% and a 65.8% success rate. Morgan covers the Services sector, focusing on stocks such as Encompass Health Corporation, Fresenius Medical Care Corp, and Envision Healthcare.
UnitedHealth has an analyst consensus of Strong Buy, with a price target consensus of $286.20, implying a 14.3% upside from current levels. In a report issued on July 5, Cantor Fitzgerald also reiterated a Buy rating on the stock with a $300 price target.
.
See today’s analyst top recommended stocks >>
The company has a one-year high of $259.01 and a one-year low of $186. Currently, UnitedHealth has an average volume of 2.69M.
Based on the recent corporate insider activity of 179 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
